Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument

Implementation Science

Deborah K Mayer⁴  Adrian A Gerstel⁴  Devon K Check²  Lisa D DiMartino²  Jennifer S Walker³  Shellie D Ellis¹  Sarah A Birken² 

[1] Department of Health Policy and Management, University of Kansas School of Medicine, Mail Stop 3044, 3901 Rainbow Boulevard, Kansas City 66160, KS, USA;Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, 1103E McGavran-Greenberg, 135 Dauer Drive, Campus Box 7411, Chapel Hill 27599-7411, NC, USA;Health Sciences Library, The University of North Carolina at Chapel Hill, 335 S. Columbia Street, Chapel Hill 27599-7585, NC, USA;School of Nursing, University of North Carolina at Chapel Hill, 2800 Carrington Hall CB# 7460, Chapel Hill 27599, NC, USA

关键词: Quality appraisal;    Dissemination;    Guidelines;    Survivorship care plan;   

Others  :  1218380
DOI  :  10.1186/s13012-015-0254-9

 received in 2015-01-09, accepted in 2015-04-22,  发布年份 2015

【 摘 要 】

Background

Survivorship care plans (SCPs) are written treatment summaries and follow-up care plans that are intended to facilitate communication and coordination of care among survivors, cancer care providers, and primary care providers. A growing number of guidelines for the use of SCPs exist, yet SCP use in the United States remains limited. Limited use of SCPs may be due to poor quality of these guidelines. The purpose of the study was to evaluate the quality of guidelines for SCP use, tools that are intended to promote evidence-based medicine.

Methods

We conducted a comprehensive search of the literature using MEDLINE/PubMed, EMBASE (Excerpta Medica Database), and CINAHL (Cumulative Index to Nursing and Allied Health Literature) published through April 2014, in addition to grey literature sources and bibliographic and expert reviews. Guideline quality was assessed using the AGREE II instrument (Appraisal of Guidelines for Research and Evaluation, 2nd edition), a tool developed by an international group of scientists to advance the quality of clinical practice guidelines. To promote consistency with extant studies using the AGREE II instrument and to clearly and unambiguously identify potentially useful guidelines for SCP use, we also summarized AGREE II scores by strongly recommending, recommending, or not recommending the guidelines that we evaluated.

Results

Of 128 documents screened, we included 16 guidelines for evaluation. We did not strongly recommend any of the 16 guidelines that we evaluated; we recommended 5 and we did not recommend 11. Overall, guidelines scored highest on clarity of presentation (i.e., guideline language, structure, and format): Guidelines were generally unambiguous in their recommendations that SCPs should be used. Guidelines scored lowest on applicability (i.e., barriers and facilitators to implementation, implementation strategies, and resource implications of applying the guideline): Few guidelines discussed facilitators and barriers to guideline application; advice and tools for implementing guidelines were vague; and none explicitly discussed resource implications of implementing the guidelines.

Conclusions

Guidelines often advocated survivorship care plan use without justification or suggestions for implementation. Improved guideline quality may promote survivorship care plan use.

【 授权许可】

   
2015 Birken et al.; licensee BioMed Central.

【 参考文献 】

• [1]Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T et al.. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62:220-41.
• [2]Cancer program standards 2012: ensuring patient-centered care, V1.1. [https://www.facs.org/quality%20programs/cancer/coc/standards].
• [3]Forsythe LP, Parry C, Alfano CM, Kent EE, Leach CR, Haggstrom DA et al.. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst. 2013; 105:1579-87.
• [4]Birken SA, Deal AM, Mayer DK, Weiner BJ. Following through: the consistency of survivorship care plan use in United States cancer programs. J Cancer Educ. 2014; 29:689-97.
• [5]Brouwers M, Kho ME, Browman GP, Cluzeau F, Feder G, Fervers B et al.. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010; 182:E839-42.
• [6]Michie S, Johnston M. Changing clinical behaviour by making guidelines specific. BMJ. 2004; 328:343-5.
• [7]Michie S, Lester K. Words matter: increasing the implementation of clinical guidelines. Qual Saf Health Care. 2005; 14:367-70.
• [8]Birken SA, Deal AM, Mayer DK, Weiner BJ. Following through: the consistency of survivorship care plan use in United States Cancer Programs. J Cancer Educ. 2014; 28:28.
• [9]Merport A, Lemon SC, Nyambose J, Prout MN. The use of cancer treatment summaries and care plans among Massachusetts physicians. Support Care Cancer. 2012; 20:1579-83.
• [10]Chubak J, Tuzzio L, Hsu C, Alfano CM, Rabin BA, Hornbrook MC et al.. Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract. 2012; 8:184-9.
• [11]Birken SA, Mayer DK, Weiner BJ. Survivorship care plans: prevalence and barriers to use. J Cancer Educ. 2013; 28:290-6.
• [12]Hahn EE, Ganz PA. Survivorship programs and care plans in practice: variations on a theme. J Oncol Pract. 2011; 7:70-5.
• [13]Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007; 25:2270-3.
• [14]IOM (Institute of Medicine). Clinical practice guidelines we can trust. Washington, DC: The National Academies Press; 2011.
• [15]Makarski J, Brouwers MC, Enterprise A. The AGREE Enterprise: a decade of advancing clinical practice guidelines. Implement Sci. 2014; 9:103. BioMed Central Full Text
• [16]AGREE: advancing the science of practice guidelines. [http://www.agreetrust.org/].
• [17]Guo J, Cheng C, Yan W, Xu G, Feng J, Wang T et al.. Systematic review of clinical practice guidelines related to multiple sclerosis. PLoS ONE. 2014; 9: Article ID e106762
• [18]Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, Tam KW. Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Med. 2013; 11:191. BioMed Central Full Text
• [19]Alberta Health Services. Follow-up care for early-stage breast cancer: Clinical Practice Guideline BR-013 version 1. 2013.
• [20]Comprehensive Cancer Centre of the Netherlands. Cancer Survivorship Care: Nationwide Guideline, Version 1.0. 2011.
• [21]Department of Health, Macmillan Cancer Support, NHS Improvement. The National Cancer Survivorship Initiative Vision. 2010.
• [22]National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment. London (UK): National Institute for Health and Clinical Excellence; 2009.
• [23]National Breast and Ovarian Cancer Centre. Recommendations for follow-up of women with early breast cancer. Australia: Cancer Australia; 2010.
• [24]Bilotti E, Faiman BM, Richards TA, Tariman JD, Miceli TS, Rome SI et al.. Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the International Myeloma Foundation Nurse Leadership Board. Clin J Oncol Nurs. 2011; 15 Suppl:5-8.
• [25]A National Coalition for Cancer Survivorship and Institute of Medicine National Cancer Policy Forum Workshop, The Lance Armstrong Foundation and The National Cancer Institute, Maria H, Patricia A, Ganz R. Implementing cancer survivorship care planning. Washington D.C: National Academies Press; 2007.
• [26]Blaseg K, Kile M, Salner A. Survivorship & palliative care: a comprehensive approach to a survivorship care plan. Oncology Issues. 2011;May/June:26.
• [27]McCabe MS, Bhatia S, Oeffinger KC, Reaman GH, Tyne C, Wollins DS et al.. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013; 31:631-40.
• [28]National Cancer Survivorship Resource Center systems policy and practice: clinical survivorship care overview. The George Washington Cancer Institute, Washington, D.C.; 2011.
• [29]The Livestrong Essential Elements of Survivorship Care. Definitions and Recommendations. [http://images.livestrong.org/downloads/flatfiles/what-we-do/our-approach/reports/ee/Essential-Elements-Definitions_Recommendations.pdf?_ga=1.31862652.376027981.1399921115].
• [30]NCCN Clinical Practice Guidelines in Oncology: Survivorship, version 1.2013. [www.nccn.org].
• [31]President’s Cancer Panel 2003–2004 Annual Report. [http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp03-04rpt/Survivorship.pdf].
• [32]Hewitt ME, Ganz P. From Cancer Patient to Cancer Survivor: Lost in Transition. National Academies Press, Washington, D.C; 2006.
• [33]Association of Community Cancer Centers Cancer Program Guidelines. [http://www.accc-cancer.org/publications/pdf/cancerprogramguidelines.pdf].
• [34]Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. J Clin Oncol. 2013; 31:2563-8.
• [35]Birken SA, Deal AM, Mayer DK, Weiner BJ. Determinants of survivorship care plan use in US cancer programs. J Cancer Educ. 2014; 29:720-7.
• [36]Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013; 8:139. BioMed Central Full Text